Use Alkermes Inc. management performance with your portfolios to protect against small markets fluctuations as well as to determine Stock diversification method that is right for you.
Alkermes Management Effectiveness
The company has return on total asset (ROA) of (5.85) % which means that it has lost $5.85 on every $1 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (18.25) % meaning that it created substantial loss on money invested by shareholders.
Alkermes Profit Margins
The company has Profit Margin (PM) of (29.15) % which may suggest that it does not properly executes on its current pricing strategies or is unable to controls all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (22.64) % which suggests for every dolor of sales it generated a net operating loss of -0.23.
Alkermes Inc. is rated third in number of employees category among related companies. The total workforce of Drug Delivery industry is presently estimated at about 23,621. Alkermes holds roughly 600 in number of employees claiming about 2.54% of equities under Drug Delivery industry.
Mr. Richard F. Pops is Chairman of the Board, Chief Executive Officer of Alkermes Public Limited Co., since September 16, 2011. Until September 2011, Mr. Pops was Chief Executive Officer, President and Chairman of the Bo...
Ms. Kathryn L. Biberstein is Senior Vice President Government Relations and Public Policy, Chief Compliance Officer, General Counsel, Secretary of Alkermes PLC. She is employed by Alkermes, Inc. ...
Alkermes employes about 600 people. The company is managed by 17 executives with total tenure of roughly 15 years, averanging almost 0.0 years of service per executive having 35.0 employee per reported executive.
Return on Alkermes Manpower
Revenue Per Employee
650 K
Revenue Per Executive
22.9 M
Net Loss Per Employee
189.5 K
Net Loss Per Executive
6.7 M
Working Capital Per Employee
416.6 K
Working Capital Per Executive
14.7 M
Alkermes Earnings Per Share
According to company disclosure Alkermes Inc. has Earnings Per Share of -0.99 times. This is 193.4% lower than that of Healthcare sector, and 290.38% lower than that of Drug Delivery industry, The Earnings Per Share for all stocks is 166.0% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
